University of Michigan
1st Floor Michigan Union
530 S. State Street
Ann Arbor
Michigan
48109
United States
Tel: 734-764-1817
Fax: 734-763-9556
Website: http://www.umich.edu/
Email: info@umich.edu
About University of Michigan
The University of Michigan, with its size, complexity, and academic strength, the breadth of its scholarly resources and the quality of its faculty and students, is one of America's great public universities and one of the world's premiere research institutions.At the University of Michigan, we're breaking new ground every day with exciting developments in the fields of life sciences, technology, medicine, and engineering. And, in the process, we're making an impact beyond our campuses. The practical applications of UM research are benefiting our lives right now. From the invention of a new, inhaled flu vaccine to the creation of software that helps children learn science, to the invention of the first bio-artificial kidney, UM technology is contributing to the betterment of human life.
UM Tech Transfer works to effectively transfer such University technologies to the market.
In the past five years, UM Tech Transfer has executed 267 technology license agreements, created 34 new startup businesses, and generated licensing revenues to stimulate additional research and discovery. Just as importantly, it has created connections between UM's renowned researchers and scientists and an ever-increasing set of partners with the resources and capabilities to fulfill the potential of UM discoveries.
If you are interested in finding out about UM technology and how it might be able to help solve the problems being faced by your company, please feel free to call the offices of UM Tech Transfer, or visit their web site and search the comprehensive listing of currently available technologies.
www.techtransfer.umich.edu 734-763-0614
Founded: 1817 President: Mary Sue Coleman Campuses: Ann Arbor, Dearborn, Flint Enrollment: 53,000 on all campuses
Research Funding: FY 02 $656,000,000 Campus: 3,177 acres; 315 major buildings Budget: FY 02 $3.6 billion
Ann Arbor Facts Enrollment: 38,000 students Regular Faculty: 3,700 Alumni: 420,000 Academic offerings: 600 degree programs
Hospitals University Hospital C.S. Mott Children's Hospital Women's Hospital
Last Updated: 09-19-02
556 articles about University of Michigan
-
Walden Biosciences Expands Research Collaboration with the University of Michigan
1/10/2024
Walden Biosciences, Inc. today announced that it has broadened its research collaboration with the University of Michigan at Ann Arbor (U-M).
-
Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan
1/4/2024
Tryp Therapeutics Inc. is pleased to announce that the first patient has been dosed in a Phase 2a clinical trial being conducted by the University of Michigan in a collaboration with Tryp Therapeutics.
-
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
11/28/2023
NanoVibronix, Inc. today announced it has signed a Research Agreement with the Regents of the University of Michigan for a Randomized Control Trial (“RCT”) study of UroShield.
-
Activated University of Michigan as The Second Site for Clinical Trial in Severe Esophageal Disease
8/28/2023
Harvard Apparatus Regenerative Technology, Inc. announced that it officially activated the second site with University of Michigan for its clinical trial as to severe esophageal disease, being its first clinical trial in the United States.
-
Cantex and Michigan Medicine Announce Initiation of a Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Clinical Study to Determine the Safety and Efficacy of Azeliragon in the Treatment of Patients Hospitalized for COVID-19
4/20/2023
Cantex Pharmaceuticals, Inc. and Michigan Medicine, a part of the University of Michigan and one of the nation's leading academic medical centers, announced today the initiation of a randomized double-blind, placebo-controlled, multicenter, phase 2/3 clinical study to evaluate the safety and efficacy of azeliragon in decreasing the incidence of acute kidney injury and other life-threatening complications in patients hospitalized for COVID-19.
-
Professors Anna Schwedenman¹ and Sarfaraz Niazi² awarded a $2 Million FDA grant to create novel analytical methods to reduce the cost of developing biosimilars
11/22/2022
To reduce the cost of development of the approval of biosimilars, the FDA is encouraging the introduction of novel analytical methods to establish biosimilarity, reducing more expensive and time-consuming testing.
-
CurePSP Expands Specialized Care Network for Rare Neurodegenerative Diseases
11/17/2022
CurePSP has announced the designation of Queen's Parkinson's and Movement Disorders Center in Hawaii and the Department of Neurology at the University of Michigan as CurePSP Centers of Care, bringing the total to 30 centers across the United States and Canada.
-
Blu Biotech Inc. Announces a Collaboration with University of Michigan for Sepsis and ARDS Detection
11/15/2022
Blu Biotech Inc. has formed a collaboration with University of Michigan (U-M) and its Max Harry Weil Institute for Critical Care Research and Innovation to develop the breath biomarkers for the detection of Sepsis and acute respiratory distress syndrome (ARDS).
-
Universities of Michigan and South Florida Sue Novartis Over Entresto Patents; Lawsuit Updates
8/31/2022
The University of Michigan and the University of South Florida have filed a lawsuit against Novartis, alleging the company’s cardiac drug, Entresto, infringes a cocrystal patent held by both universities. -
A fat hormone that slows liver tumor growth, a genetic map to track tumorigenesis, study that shows we inherit more than expected epigenetic information from our mothers, Alzheimer linked APOE gene protects against glaucoma.
-
Lung Cancer Mutation Consortium Sites Initiate LEADER Trial
6/2/2022
The Lung Cancer Mutation Consortium announces the initiation of trial sites at USC Norris Cancer Center, University of California-Davis, University of Michigan, and University of Washington for its fourth study, LCMC4 Evaluation of Actionable Drivers in EaRly Stage Lung Cancer, examining targeted drugs given as single agents and combinations as neoadjuvant therapies matched to specific genetic mutations.
-
Researchers have now identified 16 new genetic variants associated with severe COVID-19. For that and more research stories, continue reading.
-
SwRI Selected by ARPA-E to Create More Effective Burner to Reduce Methane Emissions
3/8/2022
Southwest Research Institute will collaborate with University of Michigan to use additive manufacturing and machine learning to create an advanced burner that will eliminate 99.5% of the methane encountered during oil production.
-
Details about the U.S. government’s contract with Pfizer for 10 million doses of Paxlovid are emerging, with some unusual elements.
-
This morning, multiple companies announced clinical and strategic collaborations to develop novel therapies and treatments for various diseases. Here are some of them.
-
University of Michigan Launches New Online Offerings to Meet Demand for Social Work and Health Care Professionals
3/23/2021
New programs, designed in partnership with iDesign, will soon enable access to online courses from Michigan's School of Social Work and Medical School, helping meet growing workforce demand in social work and learning health sciences
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Ascentage Pharma Enters into an Agreement with University of Michigan to obtain an exclusive license for a MDM2 Degrader using PROTAC Technology
11/30/2020
Ascentage Pharma announced it has entered into an agreement with the University of Michigan, through which the company may obtain the exclusive global rights to a MDM2 protein degrader developed using the Proteolysis-Targeting Chimeras technology.
-
Asalyxa Bio Launches with Novel Neutrophil-Targeting Drug Delivery Platform Technology and Lead Candidate, ASX-100, for Acute Respiratory Distress Syndrome (ARDS) and COVID-19 Patients
8/25/2020
University of Michigan spinout readies for clinical trials with lead candidate ASX-100, a novel spherical particle that releases a safe and effective anti-inflammatory agent, salicylic acid, directly to over-reactive immune cells
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.